Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Acquires Full Ownership of Zuventus Healthcare 💊📈

- Emcure Pharmaceuticals acquired 4,095,180 equity shares (20.42% stake) in Zuventus Healthcare for ₹7,249M.

- Emcure's shareholding in Zuventus increased from 79.58% to 100%, making it a wholly-owned subsidiary.

- The acquisition was approved by Emcure's Board on June 21, 2025, and completed by October 3, 2025.

- Zuventus Healthcare reported a turnover of ₹10,798.99M for FY 2024-25.

- Zuventus has shown consistent growth, with turnovers of ₹9,957.21M (FY 2022-23), ₹10,471.22M (FY 2023-24), and ₹10,798.99M (FY 2024-25).

- Zuventus, incorporated in 2002, operates primarily in India, focusing on pharmaceutical medicaments.